Disis ML - Search Results

1

Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept.

O'Meara MM, Disis ML. O'Meara MM, et al. Among authors: disis ml. OMICS. 2011 Sep;15(9):579-88. doi: 10.1089/omi.2010.0149. Epub 2011 Jul 6. OMICS. 2011. PMID: 21732821 Free PMC article. Review.

2

Issues on clinical applications of cancer vaccines.

Disis ML, Schiffman K. Disis ML, et al. J Immunother. 2001 Mar-Apr;24(2):104-5. J Immunother. 2001. PMID: 11265766 No abstract available.

3

Cancer vaccines targeting the HER2/neu oncogenic protein.

Disis ML, Schiffman K. Disis ML, et al. Semin Oncol. 2001 Dec;28(6 Suppl 18):12-20. Semin Oncol. 2001. PMID: 11774201 Review.

4

Peptide-based vaccines in breast cancer.

Disis ML, Salazar LG, Knutson KL. Disis ML, et al. Breast Dis. 2004;20:3-11. doi: 10.3233/bd-2004-20102. Breast Dis. 2004. PMID: 15687702 Review.

5

Use of tumour-responsive T cells as cancer treatment.

Disis ML, Bernhard H, Jaffee EM. Disis ML, et al. Lancet. 2009 Feb 21;373(9664):673-83. doi: 10.1016/S0140-6736(09)60404-9. Lancet. 2009. PMID: 19231634 Free PMC article. Review.

6

The ultimate in cancer chemoprevention: cancer vaccines.

Disis ML. Disis ML. Cancer Prev Res (Phila). 2010 Apr;3(4):406-9. doi: 10.1158/1940-6207.CAPR-10-0043. Epub 2010 Mar 23. Cancer Prev Res (Phila). 2010. PMID: 20332303 Review.

7

Immunologic biomarkers as correlates of clinical response to cancer immunotherapy.

Disis ML. Disis ML. Cancer Immunol Immunother. 2011 Mar;60(3):433-42. doi: 10.1007/s00262-010-0960-8. Epub 2011 Jan 8. Cancer Immunol Immunother. 2011. PMID: 21221967 Free PMC article. Review.

8

ELISpot for measuring human immune responses to vaccines.

Slota M, Lim JB, Dang Y, Disis ML. Slota M, et al. Among authors: disis ml. Expert Rev Vaccines. 2011 Mar;10(3):299-306. doi: 10.1586/erv.10.169. Expert Rev Vaccines. 2011. PMID: 21434798 Free PMC article. Review.

9

Therapeutic vaccines for ovarian cancer.

Liao JB, Disis ML. Liao JB, et al. Among authors: disis ml. Gynecol Oncol. 2013 Sep;130(3):667-73. doi: 10.1016/j.ygyno.2013.06.023. Epub 2013 Jun 22. Gynecol Oncol. 2013. PMID: 23800697 Review.

10

A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.

Disis ML, Gad E, Herendeen DR, Lai VP, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA. Disis ML, et al. Cancer Prev Res (Phila). 2013 Dec;6(12):1273-82. doi: 10.1158/1940-6207.CAPR-13-0182. Epub 2013 Oct 23. Cancer Prev Res (Phila). 2013. PMID: 24154719 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters